Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126162131 | 12616213 | 1 | I | 201508 | 20160702 | 20160802 | 20160802 | EXP | PHHY2016MX094801 | NOVARTIS | 61.96 | YR | M | Y | 90.00000 | KG | 20160802 | CN | COUNTRY NOT SPECIFIED | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126162131 | 12616213 | 1 | PS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF (80 MG), QD (10 YEARS AGO APPROXIMATELY, AT NIGHT) | 21283 | 1 | DF | TABLET | QD | ||||||
| 126162131 | 12616213 | 2 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG, Q12MO | 0 | 5 | MG | SOLUTION FOR INJECTION | |||||||
| 126162131 | 12616213 | 3 | SS | CO-DIOVAN | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 1 DF(HYDROCHLOROTHIAZIDE 12.5 MG ,VALSARTAN 160 MG), QD | Y | 0 | 1 | DF | TABLET | QD | |||||
| 126162131 | 12616213 | 4 | C | EZETIMIBE AND SIMVASTATIN | EZETIMIBESIMVASTATIN | 1 | Oral | 1 DF(EZETIMIBE 10 MG, SIMVASTATIN 20 MG), QD (10 YEARS AGO) | 0 | 1 | DF | TABLET | QD | ||||||
| 126162131 | 12616213 | 5 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 1 DF(75 MG), QD | 0 | 1 | DF | TABLET | QD | ||||||
| 126162131 | 12616213 | 6 | C | ASPIRIN PROTECT | ASPIRIN | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126162131 | 12616213 | 1 | Hypertension |
| 126162131 | 12616213 | 2 | Surgery |
| 126162131 | 12616213 | 3 | Hypertension |
| 126162131 | 12616213 | 4 | Product used for unknown indication |
| 126162131 | 12616213 | 5 | Cardiovascular event prophylaxis |
| 126162131 | 12616213 | 6 | Cardiovascular event prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126162131 | 12616213 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126162131 | 12616213 | Chest discomfort | |
| 126162131 | 12616213 | Pain in extremity | |
| 126162131 | 12616213 | Product use issue | |
| 126162131 | 12616213 | Road traffic accident |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126162131 | 12616213 | 2 | 201607 | 0 |